Skip to content

Exercise Intervention and Dexterity in Parkinson

Therapeutic Intervention in Motor Disorders in Parkinson.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01749917
Enrollment
60
Registered
2012-12-17
Start date
2012-12-31
Completion date
2015-02-28
Last updated
2016-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson

Keywords

Parkinson., Dexterity., Balance., Exercises.

Brief summary

The investigators conducted an intervention based in proprioceptive exercises and balance tasks. The investigators also carried out a brief intervention in manual dexterity. The study hypothesis is that a brief intervention in upper extremities and a exercise program can increase functionality in Parkinson.

Detailed description

Motor symptoms in Parkinson frequently affect upper extremities. This has been associated in previous studies with limitation in the performance of activities of daily living and, consequently, with a decrease in quality of life. The possibility that a brief intervention improves eye-hand dexterity in Parkinson's, may be a therapeutic option to improve the performance of activities of daily living. The investigators also conducted an intervention based in proprioceptive exercises and balance tasks to improve functionality.

Interventions

OTHERExercise program

Exercise program An brief exercise session including proprioceptive and dexterity activities

OTHERControl intervention

Active upper limb range of movement exercises for 15 minutes.

Sponsors

Universidad de Granada
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Subjects diagnosed with Parkinson attending to the Parkinson Association of Granada. * Subjects who can complete the assessment battery of tests at the beginning and at the end of the study.

Exclusion criteria

* Auditive and visual disturbances. * Cognitive problems. * Psychiatric pathology. * Sensorial disturbances. * Traumatic pathology of the hand. * Concomitant neurological conditions.

Design outcomes

Primary

MeasureTime frameDescription
Manual dexteritybaseline, 6 monthsChange from baseline to postintervention in dexterity. This is assessed using the Purdue Pegboard Test. The Purdue pegboard test is a timed physical test used to measure manual dexterity. Test subjects are asked to place small pins into holes in the pegboard using a specific hand and following a specific process.

Secondary

MeasureTime frameDescription
Grip strengthbaseline, 6 monthsGrip strength is measured using a Jamar dynamometer with a standard protocol allowing three attempts on each side. During each measurement, patients were sitting with their shoulder adducted and elbow flexed to 90°. The maximum value achieved from all six attempts was used in analyses. Kg/cm2
Pressure pain measurebaseline, 6 months.The pressure pain threshold for each site (three points in upper extremities) is assessed using the pressure algometer. All assessments were made by the same investigator. All the subjects were trained to familiarize the subjects with the pressure algometry procedure before the measures in an anatomical site different from the chosen sites for this study.
Nervous assessmentbaseline, 6 months.Neurodynamic tests are used in upper extremities. It moves most of the nerves between the neck and hand, including the median nerve, radial and ulnar, brachial plexus, spinal nerves and cervical nerve roots. The patient is placed supine position. It is measured with a goniometer.
Risk of falls.baseline, 6 months.The risk of falls is measured with the timed up and go. It measures in seconds, the time taken by an individual to stand up from a standard arm chair,walk a distance of 3 meters, turn, walk back to the chair, and sit down.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026